Alpha Teknova (NASDAQ:TKNO) Rating Increased to Strong-Buy at Roth Capital

Posted by on Aug 6th, 2026

Alpha Teknova (NASDAQ:TKNO – Get Free Report) was upgraded by stock analysts at Roth Capital to a “strong-buy” rating in a research note issued on Wednesday,Zacks.com reports.

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Alpha Teknova in a research note on Friday, July 17th. One research analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $7.00.

Read Our Latest Stock Analysis on Alpha Teknova

Alpha Teknova Stock Performance

Shares of TKNO opened at $5.61 on Wednesday. Alpha Teknova has a 12-month low of $1.91 and a 12-month high of $6.68. The business’s fifty day moving average price is $5.17 and its 200 day moving average price is $3.71. The company has a debt-to-equity ratio of 0.20, a current ratio of 4.59 and a quick ratio of 3.60. The stock has a market capitalization of $300.75 million, a PE ratio of -17.53 and a beta of 0.64.

Alpha Teknova (NASDAQ:TKNO – Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The company reported ($0.06) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.02. Alpha Teknova had a negative net margin of 41.07% and a negative return on equity of 24.32%. The business had revenue of $12.19 million during the quarter, compared to the consensus estimate of $10.95 million.

Institutional Investors Weigh In On Alpha Teknova

Hedge funds and other institutional investors have recently modified their holdings of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in Alpha Teknova during the 2nd quarter valued at about $29,000. ProShare Advisors LLC bought a new stake in Alpha Teknova during the fourth quarter worth approximately $38,000. JPMorgan Chase & Co. raised its holdings in Alpha Teknova by 123.1% during the second quarter. JPMorgan Chase & Co. now owns 8,163 shares of the company’s stock worth $40,000 after purchasing an additional 4,504 shares in the last quarter. R Squared Ltd acquired a new stake in Alpha Teknova in the first quarter worth approximately $42,000. Finally, Larson Financial Group LLC boosted its stake in Alpha Teknova by 58.5% during the 3rd quarter. Larson Financial Group LLC now owns 9,387 shares of the company’s stock valued at $58,000 after purchasing an additional 3,464 shares in the last quarter. 13.81% of the stock is currently owned by institutional investors.

Alpha Teknova Company Profile

(Get Free Report)

Alpha Teknova, Inc (NASDAQ: TKNO) is a life science tools and reagents company that develops, manufactures and distributes proprietary products to support research, drug discovery and biomanufacturing. Its offerings target academic institutions, pharmaceutical and biotechnology firms, and diagnostic developers, with a focus on high-purity reagents and optimized workflows designed to accelerate molecular biology and protein science applications.

The company’s portfolio includes molecular biology reagents, cell culture buffers, in vitro translation kits, custom recombinant proteins, high-throughput screening buffers and other specialized formulations.

Featured Articles

Receive News & Ratings for Alpha Teknova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Teknova and related companies with MarketBeat.com's FREE daily email newsletter.